Galatea Surgical Gains FDA Clearance for GalaForm 3D Plastic Surgery Scaffold

April 28, 2017

Subsidiary of Tepha, Galatea Surgical has received FDA marketing clearance for its GalaForm 3D Surgical Scaffold for use in plastic and reconstructive surgery.

The device is indicated for soft tissue support to repair, elevate and reinforce soft tissue where weakness or voids exist.

The company will launch the device at the upcoming meeting of American Society for Aesthetic Plastic Surgery in San Diego, California. — Cynthia Jessup

View today's stories